276 related articles for article (PubMed ID: 2399335)
21. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
[TBL] [Abstract][Full Text] [Related]
22. Gadopentetate dimeglumine: observations on the clinical research process.
Kieffer SA
Radiology; 1990 Jan; 174(1):7-8. PubMed ID: 2403685
[No Abstract] [Full Text] [Related]
23. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
[TBL] [Abstract][Full Text] [Related]
24. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
25. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
Sze G; Bravo S; Krol G
Radiology; 1989 Mar; 170(3 Pt 1):849-56. PubMed ID: 2916042
[TBL] [Abstract][Full Text] [Related]
26. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
Guthrie JA; Ward J; Robinson PJ
Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
[TBL] [Abstract][Full Text] [Related]
27. MR imaging of the normal meninges: comparison of contrast-enhancement patterns on 3D gradient-echo and spin-echo images.
Farn JW; Mirowitz SA
AJR Am J Roentgenol; 1994 Jan; 162(1):131-5. PubMed ID: 8273651
[TBL] [Abstract][Full Text] [Related]
28. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
Lundin P; Bergström K
Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
[TBL] [Abstract][Full Text] [Related]
29. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
30. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
[TBL] [Abstract][Full Text] [Related]
31. Sequence of enhancement of various portions of the pituitary gland on gadolinium-enhanced MR images: correlation with regional blood supply.
Tien RD
AJR Am J Roentgenol; 1992 Mar; 158(3):651-4. PubMed ID: 1739013
[TBL] [Abstract][Full Text] [Related]
32. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
33. Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.
Davis PC; Gokhale KA; Joseph GJ; Peterman SB; Adams DA; Tindall GT; Hudgins PA; Hoffman JC
Radiology; 1991 Sep; 180(3):779-84. PubMed ID: 1871293
[TBL] [Abstract][Full Text] [Related]
34. Cavernous sinus: correlation between anatomic and dynamic gadolinium-enhanced MR imaging findings.
Korogi Y; Takahashi M; Sakamoto Y; Shinzato J
Radiology; 1991 Jul; 180(1):235-7. PubMed ID: 2052701
[TBL] [Abstract][Full Text] [Related]
35. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
37. MR imaging of pituitary adenomas with sphenoid sinus invasion: characteristic MR findings indicating fibrosis.
Ishii K; Ikeda H; Takahashi S; Matsumoto K; Ishibashi T; Tazawa S
Radiat Med; 1996; 14(4):173-8. PubMed ID: 8916258
[TBL] [Abstract][Full Text] [Related]
38. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
39. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector.
Earls JP; Rofsky NM; DeCorato DR; Krinsky GA; Weinreb JC
Radiology; 1996 Dec; 201(3):705-10. PubMed ID: 8939219
[TBL] [Abstract][Full Text] [Related]
40. Dynamic gadolinium-enhanced MR imaging of the spleen: normal enhancement patterns and evaluation of splenic lesions.
Mirowitz SA; Brown JJ; Lee JK; Heiken JP
Radiology; 1991 Jun; 179(3):681-6. PubMed ID: 2027974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
